The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJH.L Regulatory News (MJH)

  • There is currently no data for MJH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR Dealing

14 Apr 2021 10:37

RNS Number : 4500V
MJ Hudson Group PLC
14 April 2021
 

RNS 14 April 2021

 

MJ Hudson Group plc

(the "Company", "Group" or "MJ Hudson")

 

PDMR Dealing

 

MJ Hudson (AIM:MJH), the integrated solutions provider to the asset management industry announces that Andrew Walsh, Director of Corporate Development and a PDMR, today purchased 20,000 ordinary shares in the Company at a price of 47.0p per share.

 

Further information is set out in the table below, in accordance with article 19(3) of the Market Abuse Regulation: 

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andrew Walsh

2. 

Reason for the Notification

a)

Position/status

PDMR - Director of Corporate Development

b)

Initial notification/Amendment

Initial

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

MJ Hudson Group plc

b)

LEI

213800PPN2SYLFTMEN54

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of nil par value

Identification code

JE00BJTLYP93 

b)

Nature of the transaction

Purchase of ordinary shares 

c)

Price(s) and Volumes

Price(s)

Volume(s)

47p per share

20,000

 

e)

Date of the transaction

14 April 2021

f)

Place of the transaction

London Stock Exchange, (AIM)

 

For further information, please contact:

 

MJ Hudson Group plc

Matthew Hudson, CEO

Andrew Walsh, IRO

Katherine Hazelden, PR Director

 

 

+44 20 3463 3200

Cenkos Securities (Nomad and Broker)

Giles Balleny

Stephen Keys

Callum Davidson

 

 

+44 20 7397 8900

Investec Bank (Joint Broker)

Christopher Baird

David Flin

+44 20 7597 5970

 

Buchanan (PR Adviser)

Stephanie Watson

Kim Looringh-van Beeck +44 20 7466 5000

 

About MJ Hudson

MJ Hudson is a one-stop-shop for advice, outsourcing, and analytics for the US$100 trillion+ asset management industry, with a focus on its fastest growing segment, alternative assets, which includes private equity, venture capital, hedge funds and real estate.

As outlined at IPO in December 2019, our strategy is to scale up through both organic growth and through M&A, adding complementary products and services and extending our geographic reach. This growth is supported by the continuing trend towards outsourcing; the growing need for specialist advice (as regulation in asset management proliferates); and the underlying expansion of the alternative assets subsector. 

 Founded in 2010 by CEO Matthew Hudson (a lawyer and former alternative assets fund manager), we have grown quickly to now support more than 1,000 clients, including 18 of the FTSE 100. Our business is transatlantic, with clients clustered around the major asset management centres of Europe and North America. Our team of 230 works out of 11 offices in those same centres.

 For more information, please visit our website: https://investors.mjhudson.com/

 Linkedin: www.linkedin.com/company/mj-hudson/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUSOKRASUSARR
Date   Source Headline
2nd Jun 20218:00 amRNSChange of Adviser
13th May 202112:19 pmRNSSIP and PDMR Dealings
12th May 20217:00 amRNSPDMR Dealing
10th May 20211:17 pmRNSPDMR Dealings
7th May 202111:36 amRNSRepayment of Director Loan
29th Apr 202111:49 amRNSEmployee Benefit Trust Share Purchases
14th Apr 202110:37 amRNSPDMR Dealing
14th Apr 20217:00 amRNSESG Partnership with MUFG
14th Apr 20217:00 amRNSSenior Debt Facility
8th Apr 20217:00 amRNSEstablishment of Share Incentive Plan
30th Mar 202112:48 pmRNSPDMR Dealing
23rd Mar 20217:00 amRNSInterim Results
16th Mar 20217:00 amRNSInvestor Presentation and Q&A
1st Mar 20217:00 amRNSLaw firm bolstered with senior hires
23rd Feb 20217:00 amRNSNotice of Results
16th Feb 202110:52 amRNSExercise of Options & PDMR Dealing
15th Feb 20213:55 pmRNSIssue of Equity
15th Feb 20217:00 amRNSAcquisition update
11th Feb 20212:11 pmRNSNotification of Major Holdings
8th Feb 20217:00 amRNSGrant of Options & PDMR Interests
3rd Feb 20217:00 amRNSInterim Trading Update
20th Jan 20217:00 amRNSExtension of director loan
5th Jan 20213:00 pmRNSIssue of Equity
30th Dec 20207:00 amRNSAcquisition
10th Dec 20204:32 pmRNSResult of AGM
18th Nov 20209:00 amRNSAnnual Report and Additional Disclosure
23rd Oct 202010:33 amRNSIssue of Equity
21st Oct 20204:53 pmRNSDirector/PDMR Shareholding
19th Oct 20204:04 pmRNSPDMR Dealings
16th Oct 202010:15 amRNSReplacement - Director/PDMR Shareholding
15th Oct 20201:10 pmRNSDirector/PDMR Shareholding
14th Oct 202011:02 amRNSPreliminary Results - Replacement
14th Oct 20207:00 amRNSAcquisition of Bridge Consulting
14th Oct 20207:00 amRNSPreliminary Results
7th Oct 20207:00 amRNSNotice of Results
30th Sep 202010:55 amRNSHolding(s) in Company
29th Sep 20207:00 amRNSAppointment of joint broker
28th Sep 20203:47 pmRNSIssue of Equity
11th Sep 20205:14 pmRNSHolding(s) in Company
1st Sep 202010:45 amRNSEBT Share Purchases
26th Aug 20207:00 amRNSEBT Purchase
19th Aug 20204:46 pmRNSHolding(s) in Company
30th Jul 20203:41 pmRNSEBT Purchase & PCA Dealings
27th Jul 20201:46 pmRNSHolding(s) in Company
24th Jul 20207:00 amRNSEBT Share Purchases
21st Jul 20207:00 amRNSEBT Share Purchases
20th Jul 20207:00 amRNSTrading Statement
17th Jul 20207:00 amRNSShare Purchases by EBT
16th Jul 20207:00 amRNSDirector/PDMR Shareholding
16th Jul 20207:00 amRNSShare Purchases by EBT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.